Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

HTGM
HTG Molecular Diagnostics Inc
stock NASDAQ

At Close
1/27/2023 3:59:30 PM EST
4.17USD0.000%(0.00)153,572
3.35Bid   4.26Ask   0.91Spread IEX
Pre-market
1/27/2023 9:19:39 AM EST
4.23USD+1.439%(+0.06)300
After-hours
1/18/2023 4:00:30 PM EST
4.29USD0.000%(0.00)0
OverviewHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
4.265M
Headquarters
Tucson, Arizona, USA
Industry
Diagnostics & Research
Next Earnings
2023-03-30 (60d)
Last Split
2022-12-211for12reverse
Related
EXELRDUSAFMDCALAXLV
HTGM Stats
Avg. Vol. 10 Day
513,144
Avg. Vol. 30 Day
1,707,031
Employees
87
Market Cap
4,265,201
Shares Out.
1,022,830
Float
859,078
On/Off Exchange
49%/51%
6 Month Beta
0.23
1 Year Beta
0.56
2 Year Beta
0.67
3 Year Beta
0.54
52 Week Low
2.38
52 Week High
39.48
SMA50
5.12
SMA200
8.34
1 Week
+1.46%
1 Month
+18.13%
3 Month
-35.65%
6 Month
-69.25%
1 Year
-87.59%
2 Year
-94.53%
5 Year
-99.40%
Jan 28, 2022
08:00AM EST  HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors.   GlobeNewswire Inc
Jan 7, 2022
01:07PM EST  Craig-Hallum Upgrades HTG Molecular Diagnostics to Buy, Raises Price Target to $8   Benzinga
Jan 6, 2022
08:13AM EST  HTG Molecular Diagnostics Sees Prelim. FY21 sales $8.9M vs $8.84M Est.   Benzinga
08:00AM EST  HTG Molecular Diagnostics Announces Certain Preliminary   GlobeNewswire Inc
Dec 22, 2021
04:07PM EST  HTG Completes HTP Product Next-Phase Development Milestone   Benzinga
More News
Profile
HTG Molecular Diagnostics Inc. is focused on NGS-based molecular profiling. The Company's proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG's customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

HTGM Stock Summary

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) stock price today is $4.17, and today's volume is 153,572. HTGM is down 0.000% today. The 30 day average volume is 1,707,031. HTGM market cap is 4.265M with 1,022,830 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC